Table 1.
Ligand | Active hTLR4/MD-2 (3FXI) | Active hMD-2 (3FXI) | Inactive hMD-2 (2E59) |
---|---|---|---|
L4 | −32.7 | −31.1 | −23.6 |
L5 | −39.2 | −36.5 | −33.2 |
L6 | −41.4 | −38.3 | −25.7 |
DOTAP | −22.6 | −22.3 | −11.1 |
Lipid IVaa | ND | −18.5b | −25.1 |
E. coli lipid Aa | −34.7 | −27.7 | ND |
Eritorana | ND | −15.6b | −23.3 |
Values are given in kcal/mol. The binding energies to active hMD-2 are extrapolated from rigid docking of the ligand conformation observed in the crystal structures, 2E59 and 1Z65, respectively. ND, not determined.
Binding energies are given for rigid docking to match the ligand conformations observed in the crystal structures.
Lipid IVA and eritoran are antagonists.